Celltrion partners with US pharmacy chain for Yuflyma sales
Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.
CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.
Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.
Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.
Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.
Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.
“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.
Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.
PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.
Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.
(责任编辑:컴퓨터)
- ·야당 29명 반란, 이재명 방탄 뚫렸다
- ·한동훈, 체포안 설명 8분 넘기자…“짧게 합시다” “왜 이리 시끄럽냐”
- ·[이번 주 리뷰]美 Fed 기준금리 동결…이재명 체포동의안 가결(18~23일)
- ·합의문도 없는 희한한 북·러 정상회담…결국 비즈니스 관계였나
- ·"KTX 꼭 타보고 싶다" 했던 김정은 "만족한 합의"…뭐길래
- ·Incheon Airport passenger traffic to recover during Chuseok holiday
- ·FSS issues advisories to fisheries cooperatives federation for W50b investment loss
- ·이준석, 눈물의 회견…尹대통령 향해 "與 묵언 수행 저주 풀라"
- ·28th BIFF comes to an end
- ·Conflict between Fifty Fifty and agency Attrakt continues to escalate
- ·'Basel Night' at Swiss Embassy in Seoul heralds Basel's cultural legacy
- ·Another suspect of Tajik duo behind S. Korean money exchange robbery nabbed
- ·28th BIFF comes to an end
- ·尹 보선 첫 반응 "선거 결과서 교훈 찾아, 지혜롭게 변화를"
- ·[Herald Interview] Alex Olle’s realistic reimagination of opera ‘Norma’ keeps art form alive
- ·Hyundai Motor shows off air mobility, drone tech at Seoul defense fair
- ·한 경기도 안 뛰고 병역 면제?…국감 오른 아시안게임 '병특'
- ·Hyundai Rotem to showcase new ground weapons systems at Seoul expo
- ·野 “與 보선 참패 후 이재명 전광석화 기소…국민 심판받을 것”
- ·PM visits Greece for talks on cooperation, World Expo bid campaign
- ·Political parties call for revision of military exemptions for athletes
- ·Hyundai Motor shows off air mobility, drone tech at Seoul defense fair
- ·대통령실 “UAE 대통령 방한 순연”…이스라엘·하마스 충돌 영향
- ·Subsidiary expansion procedure for insurers overseas to be simplified: FSC
- ·Yoon vows to sternly respond to N. Korea's threats through S. Korea
- ·윤 대통령 “국민소통·현장소통·당정소통 강화하라”
- ·Election watchdog faces calls to apologize after failing security test